As of Nov 19, 2026, 0 of 1 active firms rate MLAB a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
MLAB EPS & revenue forecast
EPS · NEXT QUARTER
$3.01
Range $3.01 – $3.01 · 1 analysts · +65% YoY
Next period, 1 analysts expect Mesa Laboratories Inc to earn $3.01 a share (range $3.01 – $3.01), versus $1.83 a year earlier. Full-year consensus is $11.52, growing to $12.17 the year after.
REVENUE · NEXT QUARTER
$64.8M
Range $64.6M – $64.9M · 1 analysts · +2% YoY
Revenue is expected to reach $64.8M (range $64.6M – $64.9M), +1.6% year-over-year. Full-year consensus is $252.3M, rising to $265.6M next year.
Top analysts covering Mesa Laboratories Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MLAB.
#1
Brandon Couillard
Wells Fargo
Neutral
$94.00-31.8% to target
Coverage
—
+ Follow
#2
TP
Tycho Peterson
Jefferies
Buy
$115.00-16.6% to target
Coverage
—
+ Follow
MLAB stock forecast FAQ
What is MLAB's average 12-month price target?+
The 1 active firms with a live target average $110.00 for Mesa Laboratories Inc over the next 12 months, ranging from a $110.00 high to a $110.00 low, as of Nov 19, 2026.
Is MLAB stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 1 active firms as of Nov 19, 2026, 0 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover MLAB?+
1 active firms have a recognized rating on Mesa Laboratories Inc as of Nov 19, 2026, and 1 active firms carry a live 12-month price target.
Who is the most accurate analyst covering MLAB?+
Among analysts who currently cover MLAB, Brandon Couillard of Wells Fargo has the strongest overall Quantellect track record. Their current call is Neutral with a $94.00 target.
What is Mesa Laboratories Inc's projected EPS for next quarter?+
The consensus estimate is $3.01 per share (range $3.01 – $3.01) across 1 analysts. Full-year EPS is projected at $11.52, rising to $12.17 the following year.
How much revenue is Mesa Laboratories Inc expected to report next quarter?+
Consensus revenue is $64.8M (range $64.6M – $64.9M). Full-year revenue is projected at $252.3M, growing to $265.6M next year.
Have analysts been upgrading or downgrading MLAB lately?+
As of Nov 19, 2026, 0 of 1 active firms rate MLAB a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MLAB calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.